Freeman 2011.
Methods | RCT comparing TOT and TVT | |
Participants | Multicentre RCT – 21 centres across the UK 192 women Inclusion criteria: women >21 years of age; USI or MUI for which SUI was the predominant symptom; must have failed with conservative measures Exclusion criteria: women with neurological disease; previous surgery for USI (those with previous prolapse surgery were not excluded); urodynamic DO or low compliance; POP extending beyond the hymen |
|
Interventions | Group A: Monarc TOT (n = 100) Group B: Gynaecare TVT (n = 92) |
|
Outcomes | Follow‐up at 4 weeks, 6 months and 12 months
|
|
Notes | The trial was a non‐inferiority design. Outcome measures calculated by intention‐to‐treat Assessed via ICIQ‐FLUTS long form, ICIQ LUTSqol; KHQ questionnaires and 4‐day urinary diary Sexual function assessed by ICIQ‐LUTSqol question, ‘does your urinary problem affect your sex life?’ Cystoscopy: not mentioned whether routinely performed in either group Lost to follow‐up: Group A: 5/100; Group B: 7/92 (and 1 excluded as she did not have the operation) |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "randomisation list was stratified by study sites, using randomly permuted blocks of varying sizes of 4, 6 and 8" |
Allocation concealment (selection bias) | Low risk | Quote: "The study co‐ordinator placed a treatment into consecutively numbered opaque envelopes which were opened immediately before surgery by someone other than the surgeon. Allocation concealment was therefore ensured" |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Quote: "Patients and ward staff were blinded to the intervention group by ensuring that dressings were applied both suprapubically and to the obturator areas" |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No information |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Patients and their data accounted for |